366 related articles for article (PubMed ID: 22800580)
1. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice.
Li P; Zheng Y; Ran H; Tan J; Lin Y; Zhang Q; Ren J; Wang Z
J Control Release; 2012 Sep; 162(2):349-54. PubMed ID: 22800580
[TBL] [Abstract][Full Text] [Related]
2. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
You Y; Liang X; Yin T; Chen M; Qiu C; Gao C; Wang X; Mao Y; Qu E; Dai Z; Zheng R
Theranostics; 2018; 8(6):1665-1677. PubMed ID: 29556348
[TBL] [Abstract][Full Text] [Related]
3. Estimating the delivery efficiency of drug-loaded microbubbles in cancer cells with ultrasound and bioluminescence imaging.
Liao AH; Li YK; Lee WJ; Wu MF; Liu HL; Kuo ML
Ultrasound Med Biol; 2012 Nov; 38(11):1938-48. PubMed ID: 22929655
[TBL] [Abstract][Full Text] [Related]
4. Improving acute cardiac transplantation rejection therapy using ultrasound-targeted FK506-loaded microbubbles in rats.
Liu J; Chen Y; Wang G; Jin Q; Sun Z; Lv Q; Wang J; Yang Y; Zhang L; Xie M
Biomater Sci; 2019 Sep; 7(9):3729-3740. PubMed ID: 31403142
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro evaluation of an ultrasound-triggered drug delivery system: 10-hydroxycamptothecin loaded PLA microbubbles.
Hou Z; Li L; Zhan C; Zhu P; Chang D; Jiang Q; Ye S; Yang X; Li Y; Xie L; Zhang Q
Ultrasonics; 2012 Sep; 52(7):836-41. PubMed ID: 22542992
[TBL] [Abstract][Full Text] [Related]
6. Effect of high intensity focused ultrasound (HIFU) in conjunction with a nanomedicines-microbubble complex for enhanced drug delivery.
Han H; Lee H; Kim K; Kim H
J Control Release; 2017 Nov; 266():75-86. PubMed ID: 28928042
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
[TBL] [Abstract][Full Text] [Related]
8. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Zhu H; Cao J; Cui S; Qian Z; Gu Y
J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy.
Moon H; Kang J; Sim C; Kim J; Lee H; Chang JH; Kim H
J Control Release; 2015 Nov; 218():63-71. PubMed ID: 26432554
[TBL] [Abstract][Full Text] [Related]
10. Lipid/PLGA Hybrid Microbubbles as a Versatile Platform for Noninvasive Image-Guided Targeted Drug Delivery.
Chen Y; Liang Y; Jiang P; Li F; Yu B; Yan F
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41842-41852. PubMed ID: 31633326
[TBL] [Abstract][Full Text] [Related]
11. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
12. Preparation of novel curcumin-loaded multifunctional nanodroplets for combining ultrasonic development and targeted chemotherapy.
Ji G; Yang J; Chen J
Int J Pharm; 2014 May; 466(1-2):314-20. PubMed ID: 24657138
[TBL] [Abstract][Full Text] [Related]
13. Irinotecan delivery by microbubble-assisted ultrasound: in vitro validation and a pilot preclinical study.
Escoffre JM; Novell A; Serrière S; Lecomte T; Bouakaz A
Mol Pharm; 2013 Jul; 10(7):2667-75. PubMed ID: 23675982
[TBL] [Abstract][Full Text] [Related]
14. Drug Delivery from a Multi-faceted Ultrasound Contrast Agent: Influence of Shell Composition.
Jablonowski LJ; Teraphongphom NT; Wheatley MA
Mol Pharm; 2017 Oct; 14(10):3448-3456. PubMed ID: 28814080
[TBL] [Abstract][Full Text] [Related]
15. A Novel Microbubble Capable of Ultrasound-Triggered Release of Drug-Loaded Nanoparticles.
Wang J; Li P; Tian R; Hu W; Zhang Y; Yuan P; Tang Y; Jia Y; Zhang L
J Biomed Nanotechnol; 2016 Mar; 12(3):516-24. PubMed ID: 27280249
[TBL] [Abstract][Full Text] [Related]
16. Shell effects on acoustic performance of a drug-delivery system activated by ultrasound.
Jablonowski LJ; Cochran MC; Eisenbrey JR; Teraphongphom NT; Wheatley MA
J Biomed Mater Res A; 2017 Nov; 105(11):3189-3196. PubMed ID: 28771937
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells.
Yan F; Li X; Jin Q; Jiang C; Zhang Z; Ling T; Qiu B; Zheng H
Ultrasound Med Biol; 2011 May; 37(5):768-79. PubMed ID: 21458148
[TBL] [Abstract][Full Text] [Related]
18. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.
Tinkov S; Coester C; Serba S; Geis NA; Katus HA; Winter G; Bekeredjian R
J Control Release; 2010 Dec; 148(3):368-72. PubMed ID: 20868711
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-triggered imaging and drug delivery using microbubble-self-aggregate complexes.
Chung IJ; Moon H; Jeon SI; Lee HJ; Ahn CH
J Biomater Sci Polym Ed; 2022 Jan; 33(1):57-76. PubMed ID: 34503403
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound contrast-enhanced imaging and in vitro antitumor effect of paclitaxel-poly(lactic-co-glycolic acid)-monomethoxypoly (ethylene glycol) nanocapsules with ultrasound-targeted microbubble destruction.
Ma J; Xing LX; Shen M; Li F; Zhu MJ; Jin LF; Li Z; Gao F; Su Y; Duan YR; Du LF
Mol Med Rep; 2015 Apr; 11(4):2413-20. PubMed ID: 25500683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
